BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21640148)

  • 1. Kinetics of skin resealing after insertion of microneedles in human subjects.
    Gupta J; Gill HS; Andrews SN; Prausnitz MR
    J Control Release; 2011 Sep; 154(2):148-55. PubMed ID: 21640148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.
    Brogden NK; Banks SL; Crofford LJ; Stinchcomb AL
    Pharm Res; 2013 Aug; 30(8):1947-55. PubMed ID: 23761054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles.
    Baek C; Han M; Min J; Prausnitz MR; Park JH; Park JH
    J Control Release; 2011 Sep; 154(2):138-47. PubMed ID: 21586307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
    Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of microneedle geometry and supporting substrate on microneedle array penetration into skin.
    Kochhar JS; Quek TC; Soon WJ; Choi J; Zou S; Kang L
    J Pharm Sci; 2013 Nov; 102(11):4100-8. PubMed ID: 24027112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micropore closure kinetics are delayed following microneedle insertion in elderly subjects.
    Kelchen MN; Siefers KJ; Converse CC; Farley MJ; Holdren GO; Brogden NK
    J Control Release; 2016 Mar; 225():294-300. PubMed ID: 26829102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.
    Milewski M; Stinchcomb AL
    Pharm Res; 2011 Jan; 28(1):124-34. PubMed ID: 20577787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
    Shah V; Choudhury BK
    AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneedles for transdermal drug delivery: a minireview.
    Vandervoort J; Ludwig A
    Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microneedle-based drug delivery systems for transdermal route.
    Pierre MB; Rossetti FC
    Curr Drug Targets; 2014 Mar; 15(3):281-91. PubMed ID: 24144208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of insulin using microneedles in vivo.
    Martanto W; Davis SP; Holiday NR; Wang J; Gill HS; Prausnitz MR
    Pharm Res; 2004 Jun; 21(6):947-52. PubMed ID: 15212158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication, characterization and application of sugar microneedles for transdermal drug delivery.
    Nguyen HX; Banga AK
    Ther Deliv; 2017 Mar; 8(5):249-264. PubMed ID: 28361607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force.
    Davis SP; Landis BJ; Adams ZH; Allen MG; Prausnitz MR
    J Biomech; 2004 Aug; 37(8):1155-63. PubMed ID: 15212920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery.
    Park JH; Allen MG; Prausnitz MR
    J Control Release; 2005 May; 104(1):51-66. PubMed ID: 15866334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing.
    Rajabi M; Roxhed N; Shafagh RZ; Haraldson T; Fischer AC; Wijngaart WV; Stemme G; Niklaus F
    PLoS One; 2016; 11(12):e0166330. PubMed ID: 27935976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controllable coating of microneedles for transdermal drug delivery.
    Chen J; Qiu Y; Zhang S; Yang G; Gao Y
    Drug Dev Ind Pharm; 2015 Mar; 41(3):415-22. PubMed ID: 24378200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfabricated microneedles: a novel approach to transdermal drug delivery.
    Henry S; McAllister DV; Allen MG; Prausnitz MR
    J Pharm Sci; 1998 Aug; 87(8):922-5. PubMed ID: 9687334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin.
    Ghosh P; Brogden NK; Stinchcomb AL
    J Pharm Sci; 2014 Feb; 103(2):652-60. PubMed ID: 24395718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.